3D Printed Drugs Market 2022 - Global Production Cost, Regional Demand, Technology Analysis, & New Future Enhancement Study by 2032


 The global 3D Printed Drugs Market is expected to reach a valuation of US$ 742.88 Mn in 2032, with the market expanding at a stellar CAGR of 9.2% from 2022 to 2032. The target market will likely generate an estimated US$ 307.54 Mn by the end of 2022. Large-scale applications in the healthcare sector along with the rise of chronic ailments fuel the growth of the 3D printed drugs market during the forecast period.

Quick solubility and customizable aspect of 3D printed drugs augments the demand for the same in the international market. These drugs are produced by the help of powder bed inkjet printing by adding the drug's components in a layer by layer format- similar to 3D printing for any other application. This process of production makes the medications easier to swallow and is advantageous for people suffering from dysphagia.

Request Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-2336

Moreover, 3D printing has the potential to fasten up the arrival of customized pharmaceuticals or the development of therapeutic blends. With the help of 3D printing, medications could be personalized for each patient, which will likely be more effective than batch-produced medications as they would be produced individually with consideration for that patient's medical history. All of these considerations aid the growth of the 3D printed drugs market during the forecast period.

“A surge in the demand for customized medications will fuel the global growth of the 3D printed drugs market over the forecast period,” says an FMI analyst.  

Key Takeaways:

  • The inkjet printer technology segment will hold 24% of the 3D printed drugs market share by the end of 2022.
  • The hospitals and clinics end-user segment will own about 45% of the overall market share.
  • In 2022, the 3D printed drugs market in North America will account for 31.1% of the total market share.
  • Europe’s 3D drug printing market will hold 29.9% of the market share in 2022.
  • Immense potential for 3D printed drugs research will drive the Asia Pacific market to hold 27% of the overall market share in 2022.

Competitive Landscape 

Hewlett Packard Caribe, Merck, Cycle Pharmaceuticals, AstraZeneca, Aprecia, Osmotica Pharmaceuticals, Aprecia Pharmaceuticals LLC Extend Biosciences, Bioduro, Affinity Therapeutics, GlaxoSmithKline Plc, and FabRx Ltd. among others are some of the major players in the 3D printed drugs market profiled in the full version of the report.

Key market players are focusing on product development and new product launches to meet the growing demand. These organizations also employ strategic partnership and collaboration tactics to gain a competitive advantage.

More Insights into 3D Printed Drugs Market Report

In its latest report, FMI offers an unbiased analysis of the global 3D printed drugs market, providing historical data from 2017 to 2021 and forecast statistics for 2022 to 2032. To understand the global market potential, growth, and scope, the market is segmented on the basis of the dosage form (3D printed tablets, 3D printed capsules, 3D printed multi drug implants, 3D printed nanoparticles, 3D printed solutions, other 3D printed drug dosage forms), technology (inkjet 3D printed drugs, direct write 3D printed drugs, zip dose 3D printed drugs, thermal inkjet 3D printed drugs, 3D printed drugs based on fuel deposition modeling, powder bed 3D printed drugs, stereo lithography (SLA) 3D printed drugs, semi solid extrusion (SSE) 3D printed drugs), and region.

According to the latest FMI reports, based on segmentation, the inkjet printer technology will gain momentum over the forecast period. This segment will likely account for 24% of the 3D printed drugs market share in 2022. Owing to technological advancement the inkjet printers are easier and convenient to use. In terms of end use, hospitals and clinics are expected to be major contributors to the overall growth of the target market As easy installation and fewer waste fasten up the manufacture of 3D printed drugs in hospitals and clinics, these end users are predicted to hold 45% of the overall market share.

Based on region, the 3D printed drugs market in North America will exhibit impressive growth during 2022-2032. Increasing incidences of chronic diseases, an aging population, access to a well-established healthcare infrastructure are some of the factors that drive the target market in this region. Thus, the 3D printed drugs market in North America will account for 31.1% of the total market share in 2022. Besides North America, Europe and the Asia Pacific regions, too, will register considerable 3D printed drugs market growth during the forecast period. 

Key Companies Profiled

  • Hewlett Packard Caribe
  • Merck
  • Cycle Pharmaceuticals
  • AstraZeneca
  • Aprecia
  • Osmotica Pharmaceuticals
  • Aprecia Pharmaceuticals LLC
  • Extend Biosciences
  • Bioduro
  • Affinity Therapeutics
  • GlaxoSmithKline Plc
  • FabRx Ltd

Key Segments Covered in the 3D Printed Drugs Industry Analysis

3D Printed Drugs Market by Dosage Form:

  • 3D Printed Tablets
  • 3D Printed Capsules
  • 3D Printed Multi Drug Implants
  • 3D Printed Nanoparticles
  • 3D Printed Solutions
  • Other 3D Printed Drug Dosage Forms

3D Printed Drugs Market by Technology:

  • Inkjet 3D Printed Drugs
  • Direct Write 3D Printed Drugs
  • Zip Dose 3D Printed Drugs
  • Thermal Inkjet 3D Printed Drugs
  • 3D Printed Drugs based on Fused Deposition Modeling
  • Powder Bed 3D Printed Drugs
  • Stereo Lithography (SLA) 3D Printed Drugs
  • Semi Solid Extrusion (SSE) 3D Printed Drugs

Comments

Post a Comment

Popular posts from this blog

Teleradiology Services Market Analysis And Demand With Forecast Overview To 2032

Image
 In 2022, it is expected that the Teleradiology Services Market would be worth around US$ 31,880.57 Million. By 2032, it is anticipated that the market for teleradiology services would reach US$5,598.3 Million. with a 19% CAGR growth forecast through 2032. The global Teleradiology Services Market is estimated to reach a market valuation of US$ 1,971.4 Million by the end of 2016 and register a CAGR of 21.0% over the forecast period (2016–2026). The growth of this market can be attributed to the favorable government initiatives regarding the adoption of teleradiology in order to provide early disease diagnosis. Besides, the application of modern-day technologies such as the adoption of cloud-based technologies, blockchain, and cryptocurrencies will lead to better efficiency and cost-effective solutions. Increasing Investments for the development of advanced solutions is augmenting the demand for the industry. Request Sample PDF Brochure: https://www.futuremarketinsights.com/reports/...
Read more

Non-Vascular Stents Market to 2032 – Global Analysis and Forecasts by Types, Technologies, Applications and End-User Verticals

Image
 The Non-Vascular Stents Market is expected to grow at a CAGR of  4.5%  over the forecast period. (2022 - 2032). The sector is expected to be valued at  US$ 1.21 billion  in 2022 and  US$ 1.9 billion by 2032. The global non-vascular stents market is expected to move forward in response to the growing demand for minimally-invasive procedures. Rising technological and material advancements are assisting in the development of specially designed stents for use in a variety of indications thereby fueling the overall non-vascular stents market growth. Non-vascular stents use small, precise incisions, resulting in scars that are smaller and less visible than those left by traditional surgical techniques, putting the patient's safety in jeopardy. The above-mentioned feature is anticipated to provide impetus to the non-vascular stents market adoption trends in coming years. Such a surgery is associated with a faster recovery period, resulting in a shorter hospital ...
Read more

From X-rays to AI: Veterinary Imaging Innovations of the Next Decade By 2022 to 2030

Image
  Between 2022 and 2030, the global veterinary imaging industry is expected to grow at a CAGR of 6.6%, from US$ 2.02 billion in 2022 to US$ 3.37 billion by 2030. A study by Future Industry Insights (FMI) predicted that by 2030, the worldwide veterinary imaging industry would bring in US$ 3.37 billion. The research study looks at the market development for veterinary imaging through 2030 in more than 20 nations. The report offers precise insights into some of the key players in the industry's crucial business strategies. According to the poll, investments are being made in the veterinary diagnostics industry as the trend towards pet humanization picks up speed. Additionally likely to fuel industry growth are governmental rules and a greater emphasis on preserving animal health. Request A Report Sample To Gain Comprehensive Insights! https://www.futuremarketinsights.com/reports/sample/rep-gb-12368 Growth will also be fueled by the expansion of the animal and pet care industry as a w...
Read more